REGN
eylea hd aflibercept injection 8 mg applications for expanded u s label and prefilled syringe receive fda review period extension
Wednesday, August 20, 2025 1 min read
Key Takeaway: eylea hd aflibercept injection 8 mg applications for expanded u s label and prefilled syringe receive fda review period extension
Full Press Release Details
eylea hd aflibercept injection 8 mg applications for expanded u s label and prefilled syringe receive fda review period extension.